#Pharmaceuticals — FinScans

News 📈 Stocks

Cencora Shares Rise 18.5% in 3 Months Despite 52-Week Lag Against Dow

September 10, 2026 (38 days ago)

Cencora shares show bullish momentum after a Q3 earnings beat, though the stock continues to trail peer Cardinal Health's 60% annual gain.

DOWI COR CAH

🌍 AMERICAS Read More →

News 📈 Stocks

Eli Lilly Maintains Buy Rating With $1,220 Target Amid 47% Revenue Growth

September 10, 2026 (38 days ago)

Eli Lilly continues to command a premium valuation as its GLP-1 engine drives 47% revenue growth, with analysts setting a $1,220 price…

LLY NVO MRK

🌍 GLOBAL Read More →

News 📈 Stocks — 📈 Bullish

Goldman Sachs Adds Vertex Pharmaceuticals to Conviction List Amid Pipeline Push

September 10, 2026 (38 days ago)

Vertex Pharmaceuticals earns a spot on Goldman Sachs' conviction list as the biotech leverages its dominant cystic fibrosis cash flow to fund…

🌍 NORTH AMER Read More →

News 📈 Stocks

LB Pharmaceuticals Stock Triples as Investors Eye Takeover Potential

September 9, 2026 (39 days ago)

Shares of LB Pharmaceuticals have surged over 200% in the last year, fueled by optimism surrounding its proprietary oral benzamide formulation and…

BMY JNJ

🌍 NORTH AMER Read More →

News 📈 Stocks

Fresenius Raises Profit Forecast as Hospitals, Drugs Drive Growth

August 5, 2026 (75 days ago)

Fresenius raised its earnings guidance, citing accelerating growth in its hospital and drug units, reinforcing a bullish case for the healthcare stock.

FRE.DE

🌍 EU Read More →

News 📈 Stocks

AstraZeneca Shares Drop on Report of Mega-Merger Talks With Bristol Myers

August 3, 2026 (77 days ago)

AstraZeneca shares fell on news of preliminary merger talks with Bristol Myers, sparking investor concerns over deal execution and antitrust risks.

AZN BMY

🌍 GB Read More →

News 📈 Stocks

AbbVie Q2 Earnings Top Estimates; Botox Demand Revival Lifts Outlook

July 31, 2026 (79 days ago)

AbbVie beat Q2 earnings estimates fueled by Botox demand revival, sending shares higher.

ABBV

🌍 US Read More →

News 📈 Stocks

Apnimed Aims to Raise $160 Million in US IPO With Shionogi Backing

July 28, 2026 (82 days ago)

Shionogi-backed biotech Apnimed seeks to raise $160 million in a US IPO, highlighting investor appetite for sleep disorder treatments and cross-border healthcare…

4507

🌍 US Read More →

News 🌐 Macro

Trump Plans 100% Tariff on Generic Drugs Starting August 2028

July 22, 2026 (89 days ago)

Trump’s proposed 100% tariff on generic drugs from August 2028 shakes pharmaceutical stocks and raises fears of a new trade war front.

TEVA VTRS XLV

🌍 US Read More →

News 📈 Stocks

Apnimed IPO Filing Aims to Fund Pivotal Sleep Apnea Drug Study

July 10, 2026 (100 days ago)

Apnimed, backed by Japanese drugmaker Shionogi, files IPO to raise capital for Phase 3 trial of oral sleep apnea therapy, targeting a…

4507

🌍 US Read More →

News 📈 Stocks

AstraZeneca Stock Tumbles as Heart Drug Trial Fails

July 9, 2026 (102 days ago)

AstraZeneca stock drops following unexpected failure of a heart disease drug trial.

AZN

🌍 UK Read More →

News 📈 Stocks

Galderma Shares Plunge After FDA Rejects Botox Rival Relfydess

July 1, 2026 (110 days ago)

Galderma shares sank after the FDA rejected its Botox rival Relfydess, delaying U.S. market entry and strengthening AbbVie's grip on the aesthetics…

GALD ABBV

🌍 CH Read More →